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On the speci¿ city of aldosterone action on the cardiac L- type calcium 
channel
Gaëlle Auguste [Orateur], Gema Ruiz Hurtado, Eric Morel, Ana Maria 
Gomez, Jean- Pierre Bénitah
Inserm U769, Châtenay- Malabry, France
Over past decades, aldosterone actions beyond epithelia have emerged, 
especially on the heart. Major cardiac role of aldosterone has been unveiled 
by the bene¿ cial use of mineralocorticoid receptor (MR) blockade in heart 
failure. Notably, besides the role in ¿ brosis, these actions involved regula-
tion of ion channels. We have thus accumulated evidences of modulation of 
Ca2+ signaling in cardiomyocytes by aldosterone, both in vivo and ex- vivo, 
especially on Ca2+ inÀ ux via the L- type Ca2+ channel (Cav1.2). Here we 
analyze whether this action directly controls Cav1.2 gene expression. By using 
cultured neonatal rat cardiomyocytes, we studied the time and dose dependent 
effect of aldosterone on Cav1.2 promotor activity. Cells were transfected with 
a plasmid containing a 232Kb 5’- À anking region of rat Cav1.2 gene coupled 
to the luciferase gene- reporter and then exposed to aldosterone. We observed a 
rapid induction of luciferase transcription, as soon as 1 hour of treatment even 
with aldosterone concentration as low as 1 nM. These effects were blunted 
in the presence of MR antagonists K+- canrenoate and RU28318. We are cur-
rently determining the speci¿ city of aldosterone action through MR following 
Cav1.2 promotor induction with a constitutively active MR. This study will 
bring de¿ nitive evidences as Cav1.2 direct target of aldosterone system in 
heart which is involved in pro- arrhythmic aldosterone cardiac effects.
0290
Fgf10 regulates proliferation of right ventricular cardiomyocytes in the 
fetal heart
Francesca Rochais [Orateur], Rachel Sturny, Karim Mesbah, Lucile 
Miquerol, Robert Kelly
IBDML UMR- 7288, Marseille, France
The gene encoding ¿ broblast growth factor 10 (Fgf10) is expressed in 
cardiac progenitor cells of the second heart ¿ eld (SHF). Situated in pharyn-
geal mesoderm in the early embryo, the SHF contributes to the poles of the 
elongating embryonic heart and ultimately to the outÀ ow tract, right ventricle 
and part of the atria. Mechanisms controlling SHF deployment are crucial for 
heart development and impairment of SHF addition leads to congenital heart 
defects including conotruncal and ventricular septal defects. Fgf10 mutant 
embryos die at birth with severe defects in diverse developmental processes 
including failure of lung and limb formation; however, loss of Fgf10 does 
not have a major impact on SHF development and normal heart tube elon-
gation is observed in Fgf10- /-  embryos. Nevertheless, Fgf10- /-  hearts present 
altered morphology with abnormal positioning of the apex in the thoracic 
cavity. Despite recent advances in our understanding of fetal heart growth, 
the molecular mechanisms controlling cardiomyocyte proliferation remained 
poorly de¿ ned. Here we show that Fgf10 is involved in the regulation of fetal 
cardiomyocyte proliferation, speci¿ cally in the SHF- derived right ventricle. 
Fgf10 expression persists in the fetal heart predominantly in the right ven-
tricle, where expression of both Fgf10 and its speci¿ c receptor Fgfr2IIIb is 
observed in cardiomyocytes but not ¿ broblasts. Rates of ¿ broblast prolifera-
tion and coronary vessel and conduction system morphology in Fgf10- /- fetal 
hearts are indistinguishable from those in control hearts. However, impaired 
proliferation of right ventricular myocytes is associated with upregulation of 
the cell cycle inhibitor p27kip1, potentially contributing to altered ventricular 
morphology. Together, our results reveal complex temporal and regional spe-
ci¿ c regulation of myocyte proliferation in the developing ventricles.
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CASK, a new MAGUK protein in the heart with singular localization
Catherine Eichel [Orateur], Elise Bonnet, Gilles Dilanian, Florent Louault, 
Stéphane Hatem, Elise Balse
Inserm UMRS956- UPMC, Paris, France
MAGUK proteins are a superfamily of proteins implicated in the ancho-
ring and scaffolding of macromolecular complex in the plasma membrane. 
The MAGUK protein CASK is characterized by an N- terminal calcium/
calmodulin- dependant protein kinase domain and its capacity to translo-
cate into the nucleus where it acts as a co- activator to induce the transcrip-
tion of T- element containing genes in various cell types. However, little is 
known on CASK in the heart except that the gene is expressed. Here, we 
found that CASK was expressed in cardiomyocytes as well as cardiac ¿ bro-
blasts from both human atria and rat heart. In Situ, immunostainings revealed 
that CASK was detected at the lateral membrane of the myocytes in sharp- 
contrast with other cardiac MAGUK, SAP97 and ZO1 located at the level of 
intercalated discs. CASK belongs to the costamere complex where it coloca-
lized with syntrophin but not with vinculin, two speci¿ c components of adhe-
sion complexes of the costamere. Interestingly, CASK is also expressed in the 
nucleus of myocytes in tissue cryosections. In cultured myocytes, a common 
model for growth and hypertrophy, CASK was located at focal adhesion 
sites. Moreover, we found that CASK leaves the lateral membrane and trans-
locates to the nucleus. In cultured ¿ broblasts too, CASK is expressed both 
in the nucleus and at focal adhesion sites. Furthermore, during atrial myo-
cardial remodeling associated with dilatation and ¿ brillation, the expression 
of CASK was reduced by 30% (0.84±0.04, n=8 vs control 1.16±0.07, n=7; 
mean ± SEM; N=3; p<0.01). In conclusion, CASK is a new cardiac MAGUK 
protein which shows a unique cell localization among the MAGUK family. 
This anchoring protein likely contributes to the adhesion between myocytes 
and the extracellular matrix, by interacting with syntrophin. In the nucleus, 
CASK is expressed differently under hypertrophic conditions suggesting that 
it participates in the regulation of the transcription in mechano- transduction.
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Role des microARNs 378 et 378* dans le métabolisme cardiaque
Youssef Mallat [Orateur] (1), Eva Tritsch (1), Alexandre Prola (2), 
Anne Garnier (2), Renée Ventura- Clapier (2), Zhenlin Li (1), Mathias 
Mericskay (1)
(1) Université Pierre et Marie Curie, Aging, Stress and InÀ ammation UR4, 
Paris, France - (2) Unité INSERM U769, Faculté de Pharmacie, Châtenay- 
Malabry Cedex, France
L’inactivation du facteur de réponse au sérum SRF dans le cœur de souris 
adulte conduit à un défaut fonctionnel du myocarde aboutissant à une cardio-
myopathie dilatée. Nous avons réalisé un crible de microARN sur des échan-
tillons en absence de SRF qui nous a permis d’identi¿ er un groupe de miRs 
sous- exprimés parmi lesquels nous avons trouvé miR- 378. ce miR est loca-
lisé dans l’intron 1 du gène Ppargc1b qui code le co- activateur transcriptionel 
PGC- 1β. Ce dernier stimule l’activité de plusieurs facteurs de transcription 
qui contrôlent l’oxydation des acides gras, la glycolyse et la régulation de la 
dépense énergétique. Il est fréquent qu’un miR et son gène hôte soient impli-
qués dans des voies de signalisation reliées. Nous faisons donc l’hypothèse 
que miR- 378 joue un rôle dans le métabolisme de l’énergie cardiaque. Nous 
avons établis des modèles cellulaires (myoblastes cardiaques H9C2) de surex-
pression et d’inhibition de miR- 378 et 378* a¿ n d’identi¿ er les protéines sous 
leur contrôle. L’analyse protéomique réalisée par la technique DIGE a permis 
100% d’identi¿ cation. On retrouve 87 protéines dont 73 sous exprimées en 
présence de miR- 378 et 49 en présence de miR- 378*. En utilisant les logiciels 
de prédictions de cibles nous avons identi¿ é 22 cibles prédites parmi les 87 
protéines différentiellement exprimées. Ces microARNs semblent agir surtout 
sur les protéines de la glycolyse et l’état du cytosquelette qui pourrait lui- 
même inÀ uencer la consommation d’énergie et l’activité mitochondriale. La 
suite de ce travail consiste à cloner les régions 3’UTR des cibles pour valider 
leur interaction avec les miRs dans un essai luciférase. Nous chercherons aussi 
l’impact de l’expression des miRs sur le métabolisme oxydatif et la capacité 
des mitochondries à utiliser les substrats énergétiques. Le but de se projet est 
de mieux comprendre les mécanismes de régulation qui contrôlent l’expres-
sion des miRs et la dépense énergétique des cardiomyocytes.
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Deciphering the mechanisms behind Notch signaling in the stressed 
heart
Melanie Metrich [Orateur], April Bezdek Pomey, Corinne Berthonneche, 
Thierry Pedrazzini
University of Lausanne Medical School, Department of medicine, 
Experimental Cardiology Unit, Lausanne, Suisse
The Notch pathway plays crucial roles in the development of cardiovas-
cular system and in adult self- renewing organs. The Notch ligand Jagged1 
is upregulated in the adult damaged heart, and activates Notch1 receptor to 
control the adaptive response to stress. Speci¿ cally, it reduces cardiac hyper-
trophy and ¿ brosis. Nevertheless, the molecular mechanisms by which Notch 
receptors and ligands control cardiac remodeling remain poorly unders-
tood. Beside canonical Notch receptor activation, evidence suggests that 
membrane- bound Notch ligands also release intracellular fragments, which 
could then activate Notch receptor- independent cellular responses. In order 
to investigate Jagged1 signaling in adult cardiomyocytes and its role in 
cardiac remodeling, we generated transgenic mice with cardiomyocyte- 
speci¿ c expression of the intracellular domain of Jagged1 (J1IC) À anked 
by fused mutated estrogen receptor (mER) sequences to confer controlled 
nuclear translocation following induction by tamoxifen injection. Once in 
the nucleus, J1IC activates expression of Jagged1- speci¿ c downstream target 
genes. Transgenic mice treated with tamoxifen were subjected to transverse 
aortic constriction for one week. Interestingly, results point to an increase in 
hypertrophic gene expression (ANF, BNP, α- skeletal actin, β/α- MHC ratio) 
after J1IC nuclear translocation in transgenic mice compared to wt mice. In 
addition, N1IC positive cardiomyocytes and Notch target genes, such as Hes1 
and Hey1, were downregulated in transgenic mice treated with tamoxifen 
suggesting that J1IC inhibits Notch signaling in cardiomyocytes and thereby 
con¿ rming recent data showing that J1IC decreases N1IC binding to its trans-
cription factor RBP- Jk. 
Ongoing experiments aim at further analyzing the precise mechanism 
by which J1IC inhibits Notch signaling and induces cardiac remodeling. 
Altogether, these data present new insights into the regulation of the Notch 
pathway by its ligands.
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Isolation and Characterization of MAM Protein Complexes from Heart 
tissue
Pierre- Alain Thiébaut [Orateur], Mélanie Paillard, Michel Ovize, Ludovic 
Gomez
Inserm U1060, Lyon Cedex 08, France
Mitochondria- associated endoplasmic reticulum (ER) membrane (MAM) 
has been described as being the association between the mitochondria and the 
ER membranes. This connection was shown to play a crucial role in many cel-
lular processes such as Ca2+ transfer between ER and mitochondria. Indeed, 
MAM have been proved to be enriched in Ca2+ channels such as IP3 Receptors 
(IP3Rs) and Voltage- Dependent Anion- selective Channel protein (VDAC) but 
also chaperones like GRP75, underlying the fact that MAM and its constituents 
are important actors of Ca2+ transfer between ER and mitochondria.
In this study, we combined three complementary approaches to isolate 
and characterize the MAM protein complex in the heart tissue and H9c2 
cardiomyoblasts.
The intracellular localization of IP3R, Grp75 and VDAC was visualized by cell 
fractionation from mouse left ventricles. The protein partnerships of the MAM 
complex were con¿ rmed by 2D blue native gel on heart homogenate and the 
protein- protein proximity was measured by in situ proximity ligation assay (PLA) 
that can detect interactions within a 40 nm range with high speci¿ city in H9c2.
As previously described by Wieckowski et al. on a liver model, the Percoll 
method used for the cell fractionation, is one of the most rigorous pro-
cedure to obtain ER, MAM and mitochondrial fractions from mouse heart. 
Immunoblotting of MAM fraction showed clear detectable bands of IP3R, 
Grp75 and VDAC, whereas cytochrome c was absent in this compartment. 
The 2D blue native gel analysis showed that IP3R, Grp75 and VDAC co- 
localized in a high molecular weight complex, supporting their possible inte-
raction in the heart. Using PLA, we validated the interaction between VDAC 
and IP3R with Grp75 as intermediate.
MAM can be isolated directly from heart tissues and protein complexes can 
be analyzed in their native forms. These results suggest that IP3R/VDAC1/
GRP75 could play an important role in Ca2+ transfer between ER and mito-
chondria in the heart function.
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